Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015, Article ID 543818, 11 pages
http://dx.doi.org/10.1155/2015/543818
Research Article

Altered Expression of NF-κB and SP1 after Exposure to Advanced Glycation End-Products and Effects of Neurotrophic Factors in AGEs Exposed Rat Retinas

Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba, Chiba Prefecture 260-8670, Japan

Received 23 October 2014; Revised 4 April 2015; Accepted 4 April 2015

Academic Editor: Secundino Cigarran

Copyright © 2015 Guzel Bikbova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. B. Ruderman, J. R. Williamson, and M. Brownlee, “Glucose and diabetic vascular disease,” The FASEB Journal, vol. 6, no. 11, pp. 2905–2914, 1992. View at Google Scholar · View at Scopus
  2. J.-L. Wautier, M.-P. Wautier, A.-M. Schmidt et al., “Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface associated AGEs and diabetic complications,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 16, pp. 7742–7746, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Bikbova, T. Oshitari, and S. Yamamoto, “Neurite regeneration in adult rat retinas exposed to advanced glycation end-products and regenerative effects of neurotrophin-4,” Brain Research, vol. 1534, pp. 33–45, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. Schmidt, O. Hori, J. Brett, S. D. Yan, J.-L. Wautier, and D. Stern, “Cellular receptors for advanced glycation end products: implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 14, no. 10, pp. 1521–1528, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Vlassara, Y. M. Li, F. Imani et al., “Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex,” Molecular Medicine, vol. 1, no. 6, pp. 634–646, 1995. View at Google Scholar · View at Scopus
  6. A. M. Schmidt, R. Mora, R. Cao et al., “The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide,” The Journal of Biological Chemistry, vol. 269, no. 13, pp. 9882–9888, 1994. View at Google Scholar · View at Scopus
  7. U. Ritthaler, Y. Deng, Y. Zhang et al., “Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease,” The American Journal of Pathology, vol. 146, no. 3, pp. 688–694, 1995. View at Google Scholar · View at Scopus
  8. M. Abel, U. Ritthaler, Y. Zhang et al., “Expression of receptors for advanced glycosylated end-products in renal disease,” Nephrology Dialysis Transplantation, vol. 10, no. 9, pp. 1662–1667, 1995. View at Google Scholar · View at Scopus
  9. M. Brownlee, “Biochemistry and molecular cell biology of diabetic complications,” Nature, vol. 414, no. 6865, pp. 813–820, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. S. D. Yan, A. M. Schmidt, G. M. Anderson et al., “Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins,” Journal of Biological Chemistry, vol. 269, no. 13, pp. 9889–9897, 1994. View at Google Scholar · View at Scopus
  11. A. M. Schmidt, O. Hori, J. X. Chen et al., “Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: a potential mechanism for the accelerated vasculopathy of diabetes,” The Journal of Clinical Investigation, vol. 96, no. 3, pp. 1395–1403, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Collins, “Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion,” Laboratory Investigation, vol. 68, no. 5, pp. 499–508, 1993. View at Google Scholar · View at Scopus
  13. L. Cabal-Hierro, M. Rodríguez, N. Artime et al., “TRAF-mediated modulation of NF-κB AND JNK activation by TNFR2,” Cellular Signalling, vol. 26, no. 12, pp. 2658–2666, 2014. View at Publisher · View at Google Scholar
  14. V. Infantino, P. Convertini, F. Iacobazzi, I. Pisano, P. Scarcia, and V. Iacobazzi, “Identification of a novel Sp1 splice variant as a strong transcriptional activator,” Biochemical and Biophysical Research Communications, vol. 412, no. 1, pp. 86–91, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. N. D. Perkins, N. L. Edwards, C. S. Duckett, A. B. Agranoff, R. M. Schmid, and G. J. Nabel, “A cooperative interaction between NF-κB and Sp1 is required for HIV-1 enhancer activation,” The EMBO Journal, vol. 12, no. 9, pp. 3551–3558, 1993. View at Google Scholar · View at Scopus
  16. N. Tanaka, H. Yonekura, S.-I. Yamagishi, H. Fujimori, Y. Yamamoto, and H. Yamamoto, “The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappaB, and by 17beta-estradiol through sp-1 in human vascular endothelial cells,” The Journal of Biological Chemistry, vol. 275, no. 33, pp. 25781–25790, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Bikbova, T. Oshitari, and S. Yamamoto, “Neuronal cell death and regeneration in diseases associated with advanced glycation end-products accumulation,” Neural Regeneration Research, vol. 9, no. 7, pp. 701–702, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Oshitari, G. Bikbova, and S. Yamamoto, “Increased expression of phosphorylated c-Jun and phosphorylated c-Jun N-terminal kinase associated with neuronal cell death in diabetic and high glucose exposed rat retinas,” Brain Research Bulletin, vol. 101, pp. 18–25, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Horie, Y. Bando, H. Chi, and T. Takenaka, “NGF enhances neurite regeneration from nerve-transected terminals of young adult and aged mouse dorsal root ganglia in vitro,” Neuroscience Letters, vol. 121, no. 1-2, pp. 125–128, 1991. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Horie and M. Takano, “Tissue culture method for neural regeneration of postnatal and mature mammalian retina,” Tissue Culture Research Communications, vol. 13, no. 4, pp. 171–178, 1994. View at Google Scholar
  21. T. Oshitari, N. Yoshida-Hata, and S. Yamamoto, “Effect of neurotrophic factors on neuronal apoptosis and neurite regeneration in cultured rat retinas exposed to high glucose,” Brain Research, vol. 1346, pp. 43–51, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Oshitari, S. Yamamoto, N. Hata, and S. Roy, “Mitochondria- and caspase-dependent cell death pathway involved in neuronal degeneration in diabetic retinopathy,” British Journal of Ophthalmology, vol. 92, no. 4, pp. 552–556, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Takano, K. Sango, H. Horie et al., “Diabetes alters neurite regeneration from mouse retinal explants in culture,” Neuroscience Letters, vol. 275, no. 3, pp. 175–178, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Oshitari, M. Dezawa, S. Okada et al., “The role of c-fos in cell death and regeneration of retinal ganglion cells,” Investigative Ophthalmology and Visual Science, vol. 43, no. 7, pp. 2442–2449, 2002. View at Google Scholar · View at Scopus
  25. T. Oshitari and S. Roy, “Diabetes: a potential enhancer of retinal injury in rat retinas,” Neuroscience Letters, vol. 390, no. 1, pp. 25–30, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Oshitari, N. Yoshida-Hata, and S. Yamamoto, “Effect of neurotrophin-4 on endoplasmic reticulum stress-related neuronal apoptosis in diabetic and high glucose exposed rat retinas,” Neuroscience Letters, vol. 501, no. 2, pp. 102–106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Soulis-Liparota, M. Cooper, D. Papazoglou, B. Clarke, and G. Jerums, “Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat,” Diabetes, vol. 40, no. 10, pp. 1328–1334, 1991. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Nakamura, Z. Makita, S. Ishikawa et al., “Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation,” Diabetes, vol. 46, no. 5, pp. 895–899, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. H.-P. Hammes, S. Martin, K. Federlin, K. Geisen, and M. Brownlee, “Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 24, pp. 11555–11558, 1991. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Tamatani, Y. H. Che, H. Matsuzaki et al., “Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFκB activation in primary hippocampal neurons,” The Journal of Biological Chemistry, vol. 274, no. 13, pp. 8531–8538, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Yoshida-Hata, Y. Mitamura, T. Oshitari et al., “Transcription factor, SP1, in epiretinal membranes of patients with proliferative diabetic retinopathy,” Diabetes Research and Clinical Practice, vol. 87, no. 3, pp. e26–e28, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Yamagishi, H. Fujimori, H. Yonekura, Y. Yamamoto, and H. Yamamoto, “Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells,” Diabetologia, vol. 41, no. 12, pp. 1435–1441, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. S.-I. Yamagishi, C.-C. Hsu, M. Taniguchi et al., “Receptor-mediated toxicity to pericytes of advanced glycosylation end products: a possible mechanism of pericyte loss in diabetic microangiopathy,” Biochemical and Biophysical Research Communications, vol. 213, no. 2, pp. 681–687, 1995. View at Publisher · View at Google Scholar · View at Scopus
  34. S.-I. Yamagishi, Y. Yamamoto, S.-I. Harada, C.-C. Hsu, and H. Yamamoto, “Advanced glycosylation end products stimulate the growth but inhibit the prostacyclin-producing ability of endothelial cells through interactions with their receptors,” FEBS Letters, vol. 384, no. 1, pp. 103–106, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. A. M. Schmidt, M. Hasu, D. Popov et al., “Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 19, pp. 8807–8811, 1994. View at Publisher · View at Google Scholar · View at Scopus
  36. A. M. Schmidt, O. Hori, J. X. Chen et al., “Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes,” Journal of Clinical Investigation, vol. 96, no. 3, pp. 1395–1403, 1995. View at Publisher · View at Google Scholar · View at Scopus
  37. J.-L. Wautier, C. Zoukourian, O. Chappey et al., “Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats,” The Journal of Clinical Investigation, vol. 97, no. 1, pp. 238–243, 1996. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Park, K. G. Raman, K. J. Lee et al., “Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts,” Nature Medicine, vol. 4, no. 9, pp. 1025–1031, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Y. Zhang, Y. F. Diao, H. R. Kim, and D. I. Jin, “Inhibition of endoplasmic reticulum stress improves mouse embryo development,” PLoS ONE, vol. 7, no. 7, Article ID e40433, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Borowiak, A. N. Garratt, T. Wüstefeld, M. Strehle, C. Trautwein, and C. Birchmeier, “Met provides essential signals for liver regeneration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 29, pp. 10608–10613, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Giacobini, A. Messina, S. Wray et al., “Hepatocyte growth factor acts as a motogen and guidance signal for gonadotropin hormone-releasing hormone-1 neuronal migration,” Journal of Neuroscience, vol. 27, no. 2, pp. 431–445, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Helmbacher, E. Dessaud, S. Arber et al., “Met signaling is required for recruitment of motor neurons to PEA3-positive motor pools,” Neuron, vol. 39, no. 5, pp. 767–777, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Tönges, T. Ostendorf, F. Lamballe et al., “Hepatocyte growth factor protects retinal ganglion cells by increasing neuronal survival and axonal regeneration in vitro and in vivo,” Journal of Neurochemistry, vol. 117, no. 5, pp. 892–903, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. W. Wong, A. W. Cheung, S. Yu, O. Sha, and E. Y. Cho, “Hepatocyte growth factor promotes long-term survival and axonal regeneration of retinal ganglion cells after optic nerve injury: comparison with CNTF and BDNF,” CNS Neuroscience & Therapeutics, vol. 20, no. 10, pp. 916–929, 2014. View at Publisher · View at Google Scholar
  45. M. Trupp, E. Arenas, M. Fainzilber et al., “Functional receptor for GDNF encoded by the c-ret proto-oncogene,” Nature, vol. 381, no. 6585, pp. 785–789, 1996. View at Publisher · View at Google Scholar · View at Scopus
  46. P. D. Koeberle and A. K. Ball, “Effects of GDNF on retinal ganglion cell survival following axotomy,” Vision Research, vol. 38, no. 10, pp. 1505–1515, 1998. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Bikbova, T. Oshitari, T. Baba, and S. Yamamoto, “Neurotrophic factors for retinal ganglion cell neuropathy—with a special reference to diabetic neuropathy in the retina,” Current Diabetes Reviews, vol. 10, no. 3, pp. 166–176, 2014. View at Publisher · View at Google Scholar
  48. N. Kanda, S. Koike, and S. Watanabe, “Prostaglandin E2 enhances neurotrophin-4 production via EP3 receptor in human keratinocytes,” The Journal of Pharmacology and Experimental Therapeutics, vol. 315, no. 2, pp. 796–804, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. T. Salin, T. Timmusk, U. Lendahl, and M. Metsis, “Structural and functional characterization of the rat neurotrophin-4 gene,” Molecular and Cellular Neurosciences, vol. 9, no. 4, pp. 264–275, 1997. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Nicolás, V. Noé, K. B. Jensen, and C. J. Ciudad, “Cloning and characterization of the 5′-flanking region of the human transcription factor Sp1 gene,” The Journal of Biological Chemistry, vol. 276, no. 25, pp. 22126–22132, 2001. View at Publisher · View at Google Scholar · View at Scopus